Strategy is feasible for advanced cancers; 157 regimens were administered to 210 patients, including 103 personalized combos.

Researchers sought to determine the effectiveness of patient navigation for younger breast cancer patients, and their attendance to referrals.

An interim analysis of the prospective BIOPSTAGE trial determined optimal PET thresholds for SUVmax and SUVratio that ...

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

Decrease seen in percent of patients receiving timely treatment among those living in states with least stringent regulations.

Researchers sought to measure the confidence healthcare providers and patients have regarding future use of large-language ...

Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

Researchers determined the predictive value of the Geriatric 8 Screening tool for OS and PFS in older patients with ...

Investigator sought to determine whether nelfinavir mesylate plus chemoradiation and image-guided brachytherapy could improve disease-free survival for patients with stage III cervical cancer.

In this retrospective study, researchers explored mortality among women with breast cancer in states with and without Medicaid expansion.

No increase in risk for breast cancer seen for BRCA carriers following predominantly surgical menopause. HealthDay News — Use of menopausal hormone therapy (MHT) following menopause is not associated ...